Gradalis, Inc.
15 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide (NCT03495921) | Gradalis, Inc. | 2018-08-21 |
Track Gradalis, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.